Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning

Blood

Volumn 94, Issue 7, 1999, Pages 2271-2286

  Rosenzweig, M ^b   MacVittie, T J ^b   Harper, D ^b   Hempel, D ^b   Glickman, R L ^b   Johnson, R P ^b   Farese, A M ^b   Whiting Theobald, N ^b   Linton, G F ^b   Yamasaki, G ^b   Jordan, C T ^b   Malech, H L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; VIRUS VECTOR;

ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL THERAPY; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IRRADIATION; MALE; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REPORTER GENE; RHESUS MONKEY; T LYMPHOCYTE SUBPOPULATION;

EID: 0033214219     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.7.2271.419k41_2271_2286     Document Type: Article

References (64)

1. Donahue RE, Wang EA, Stone DK, Kamen R, Wong GG, Sehgal PK, Nathan DG, Clark SC: Stimulation of hematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 321:872, 1986
2. Dunbar CE, Cottier-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson WH, Cowan K, Young NS, Nienhuis AW: Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048, 1995
3. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Anneit G, Brooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blaese RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1:1017, 1995
4. Dube ID, Kruth S, Abrams-Ogg A, Kamel-Reid S, Lutzko C, Nanji S, Ruedy C, Singaraja R, Wild A, Krygsman P, Chu P, Messner H, Reddy V, Mcgarrity G, Stewart AK: Preclinical assessment of human hematopoietic progenitor cell transduction in long term marrow cultures. Hum Gene Ther 10:2089, 1996
5. Stewart AK, Prince HM, Cappe D, Chu P, Lutzko C, Sutherland DR, Dube ID: In vitro maintenance and retroviral transduction of human myeloma cells in long-term marrow cultures. Cancer Gene Ther 4:148, 1997
6. Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE: Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 92:1131, 1998
7. Kiem HP, Andrews RG, Morris J, Peterson L, Heyward S, Allen JM, Rasko JE, Potter J, Miller AD: Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood 92:1878, 1998
8. + progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood 89:446, 1997
9. - human hematopoietic progenitors assessed in immune-deficient mice. Blood 91:1243, 1998
10. Stewart AK, Nanji S, Krygsman P, Ruedy C, Singaraja R, Nayar R, Peck B, Sutherland DR, McGarrity G, Dubé ID: Engraftment of gene marked long term marrow culture (LTMC) cells in myeloma patients. Blood 88:270a, 1996 (abstr, suppl 1)
11. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1993
12. + cells in ADA-deflcient SCID neonates. Nat Med 4:775, 1998
13. Pawliuk R, Kay R, Landsdorp P, Humphries RK: Selection of retrovirally transduced hematopoietic cells using CD24 as amarker of gene transfer. Blood 84:2868, 1994
14. Phillips K, Gentry T, McCowage G, Gilboa E, SMITH C: Cell-surface markers for assessing gene transfer into human hematopoietic cells. Nat Med 2:1154, 1996
15. Comoli P, Dilloo D, Hutchings M, Hoffma T, Heslop HE: Measuring gene-transfer efficiency. Nat Med 2:1280, 1996
16. Mardiney MR, Malech HL: Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: Implications for gene therapy. Blood 87:4049, 1996
17. Anonymous: The Institute of Laboratory Animal Resources, National Research Council: Guide for the Care and Use of Laboratory Animals. Washington, DC, National Institutes of Health, 1996, p 86 (abstr)
18. + cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 87:1644, 1996
19. Farese AM, Herodin F, Grab LB, Varma N, Baum C, Burton E, McKearn JP, MacVittie TJ: Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced marrow aplasia. Blood 87:581, 1996
20. + peripheral blood progenitors as a target for genetic correction of the two flavocytochrome B558 defective forms of chronic granulomatous disease. Blood 84:53, 1994
21. Malech HL, Maples PB, Whiting-Theobald N, Linton GF, Sekhsaria S, Vowells SJ, Li F, Miller JA, DeCarlo E, Holland SM, Leitman SF, Carter CS, Butz RE, Read EJ, Fleisher TA, Schneiderman RD, Van Epps DE, Spratt SK, Maack CA, Rokovich JA, Cohen LK, Gallin JI: Prolonged production of NADPH oxidase-corrected granulocytes following gene therapy of chronic granulomatous disease. Proc Natl Acad Sci USA 94:12133, 1997
22. Lefkovits I, Waldmann H: Limiting dilution analysis of cells of the immune system. Cambridge, UK, Cambridge University Press, 1979, p 38
23. Fazekas de St Groth S: The evaluation of limiting dilution assays. J Immunol Methods 49:R11, 1982
24. Kawai T, Wong J, MacLean J, Cosimi AB, Wee S: Characterization of a monoclonal antibody (6G12) recognizing the cynomolgus monkey CD3 antigen. Transplant Proc 26:1845, 1994
25. Molineux G, Pojda A, Hampson IN, Lord BI, Dexter TM: Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 76:2153, 1990
26. Briddel RA, Hartley CA, Smith KA, McNiece IK: Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720, 1993
27. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Weissman IL: Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Nad Acad Sci USA 90:3760, 1993
28. Bodine DM, Seidel NE, Gale MS, Nienhuis AW, Orlic D: Efficient retrovirus transduction of mouse pluripotent hematopietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 84:1482, 1994
29. Brasel K, McKenna HJ, Charrier K, Morrissey PJ, Williams DE, Lyman SD: Flt3-Ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice. Blood 90:3781, 1997
30. de Revel T, Appelbaum FR, Storb R, Schuening F, Nash R, Deeg J, McNiece I, Andrews R, Graham T: Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 83:3795, 1994
31. Andrews RG, Briddell RA, Knitter GH, Opie T, Bronsden M, Myerson D, Appelbaum FR, McNiece IK: In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons: Enhanced circulation of progenitor cells. Blood 84:800, 1994
32. Andrews RG, Briddell RA, Knitter GH, Rowley SD, Appelbaum FR, McNiece IK: Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte coloy-stimulating factor in nonhuman primates. Blood 85:15, 1995
33. Bodine DM, Seidel NE, Zsebo KM, Orlic DB: In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 82:445, 1993
34. McNiece IK, Briddell RA, Hartley CA, Smith KA, Andrews RG: Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cells. Stem Cells 11:36, 1993
35. Dunbar CE, Seidel NE, Doren S, Sellers S, Cline AP, Metzger ME, Agricola BA, Donahue RE, Bodine DM: Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 93:11871, 1996
36. Orlic D, Girard LJ, Anderson SM, Do BK, Seidel NE, Jordan CT, Bodine DM: Transduction efficiency of cell lines and hematopoietic stem cells correlates with retrovirus receptor mRNA levels. Stem Cells 15:23, 1997 (suppl 1)
37. Orlic D, Girard LJ, Jordan CT, Anderson SM, Cline AP, Bodine DM: The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc Natl Acad Sci USA 93:11097, 1996
38. Sudo Y, Shimazaki C, Ashihara E, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N, Nakagawa M: Synergistic effect of Flt3-Ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice. Blood 89:3186, 1997
39. Molineux G, McCrea C, Yan X-Q, Kerzic P, McNiece I: Flt3-Ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential. Blood 89:3998, 1997
40. Papayannopoulou T, Nakamoto B, Andrews RG, Lyman SD, Lee MY: In vivo effects of Flt3/Flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with granulocyte colony-stimulating factor. Blood 90:620, 1997
41. + cells and hematopoietic clonogenic cells in normal nonhuman primates relative to daniplestim plus G-CSF. Exp Hematol 1999 (in press)
42. MacVittie TJ, Farese AM, Smith LD, Casey DB, Smith WG, Woulfe SL, Streeter PR, McKearn JP: Members of the progenipoietins, a family of chimeric Flt3-Ligand and G-CSF receptor antagonist mobilize hematopoietic progenitor cells with different kinetics and efficiency in nonhuman primates. Blood 92:682a, 1998 (abstr, suppl 1)
43. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239, 1990
44. Kohn DB: The current status of gene therapy using hematopoietic stem cells. Curr Opin Pediatr 7:56, 1995
45. Nolta JA, Kohn DB: Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum GeneTher 1:257, 1990
46. + hematopoietic progenitor cells measured in vitro and in vivo. Gene Ther 2:245, 1995
47. Matsunaga T, Hirayama F, Yonemura Y, Murray R, Ogawa M: Negative regulation by interleukin-3 of mouse early B-cell progenitors and stem cells in culture: Transduction of the negative signals by betac and betaIL-3 proteins of IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor. Blood 92:901, 1998
48. Hirayama F, Ogawa M: Negative regulation of early T lymphopoiesis by interleukin-3 and interleukin-1 alpha. Blood 86:4527, 1995
49. Hirayama F, Clark SC, Ogawa M: Negative regulation of early B lymphopoiesis by interleukin 3 and interleukin 1 a. Proc Natl Acad Sci USA 91:469, 1994
50. Yonemura Y, Ku H, Lyman SD, Ogawa M: In vitro expansion of hematopoietic progenitors and maintenance of stem cells: Comparison between FLT3/FLK-2 ligand and KIT ligand. Blood 89:1915, 1997
51. Nolta JA, Smogorzewska EM, Kohn DB: Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86:101, 1995
52. Lemieux ME, Chappel SM, Miller CL, Eaves CJ: Differential ability of Flt3-ligand, interleukin-11, and Steel factor to support the generation of B cell progenitors and myeloid cells from primitive murine fetal liver cells. Exp Hematol 25:951, 1997
53. + cells. Blood 92:690a, 1998 (abstr, suppl 1)
54. Hanenberg H, Hashino K, Konishi H, Hock RA, Kato I, Williams DA: Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells. Hum Gene Ther 8:2193, 1997
55. + cells using the gibbon ape leukemia virus packaging cell line, PG13. Blood 86:241a, 1995 (abstr, suppl 1)
56. + cells that are small in size and express both CD38 and Thy-1. Blood 88:645a, 1996 (abstr, suppl 1)
57. Rao SS, Peters SO, Crittenden RB, Stewart FM, Ramshaw HS, Quesenberry PJ: Stem cell transplantation in the normal nonmyeloablated host: Relationship between cell dose, schedule, and engraftment. Exp Hematol 25:114, 1997
58. van Os R, Thames HD, Konings AW, Down JD: Radiation dose-fractionation and dose-rate relationships for long-term repopulating hematopoietic stem cells in a murine bone marrow transplant model. Radiat Res 136:118, 1993
59. van Os R, Dawes D, Mislow JM, Witsell A, Mauch PM: Host conditioning with 5-fluorouracil and kit-ligand to provide for long term bone marrow engraftment. Blood 89:2376, 1997
60. Neta R, Oppenheim JJ, Schreiber RD, Chizzonite R, Ledney GD, MacVittie TJ: Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance. J Exp Med 173:1177, 1991
61. Ippoliti C, Przepiorka D, Giralt S, Andersson BS, Wallerstein RO, Gutterman J, Deisseroth AB, Champlin RE: Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation. Bone Marrow Transplant 11:55, 1993
62. de Haan G, Donte B, Engel C, Loeffler M, Nijhof W: Prophylactic pretreatment of mice with hematopoietic growth factors induces expansion of primitive cell compartments and results in protection against 5-fluorouracil-induced toxicity. Blood 87:4581, 1996
63. Zucali JR, Moreb J, Gibbons W, Alderman J, Suresh A, Zhang Y, Shelby B: Radioprotection of hematopoietic stem cells by interleukin-1. Exp Hematol 22:130, 1994
64. Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, Manley SA, Lupton SD, Overell RW, Reynolds TC, Corey L, Greenberg PD: T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Med 2:216, 1996